A
$ Value
$0
Shares
10,000
Price
$0
Filed
Dec 22
Insider
Name
Bhatia Kishor G.
Title
Chief Scientific Officer
CIK
0001812638
Roles
Officer
Transaction Details
Transaction Date
2025-12-18
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
10,000
Footnotes
The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 24-month period commencing January 18, 2026.